NOVO.B.DK

379

+2.06%↑

GMAB.DK

2,089

+3.06%↑

HLUNB.DK

45.28

+1.8%↑

ZEAL.DK

512.6

+1.75%↑

AMBUB.DK

107.1

+3.38%↑

NOVO.B.DK

379

+2.06%↑

GMAB.DK

2,089

+3.06%↑

HLUNB.DK

45.28

+1.8%↑

ZEAL.DK

512.6

+1.75%↑

AMBUB.DK

107.1

+3.38%↑

NOVO.B.DK

379

+2.06%↑

GMAB.DK

2,089

+3.06%↑

HLUNB.DK

45.28

+1.8%↑

ZEAL.DK

512.6

+1.75%↑

AMBUB.DK

107.1

+3.38%↑

NOVO.B.DK

379

+2.06%↑

GMAB.DK

2,089

+3.06%↑

HLUNB.DK

45.28

+1.8%↑

ZEAL.DK

512.6

+1.75%↑

AMBUB.DK

107.1

+3.38%↑

NOVO.B.DK

379

+2.06%↑

GMAB.DK

2,089

+3.06%↑

HLUNB.DK

45.28

+1.8%↑

ZEAL.DK

512.6

+1.75%↑

AMBUB.DK

107.1

+3.38%↑

Search

Coloplast A-S (Class B)

Uždarymo kaina

569.6 -0.14

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

556.4

Max

572.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-107M

805M

Pardavimai

28M

7B

P/E

Sektoriaus vid.

30.127

35.739

Pelnas, tenkantis vienai akcijai

4.93

Dividendų pajamingumas

3.99

Pelno marža

11.569

Darbuotojai

16,814

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.86% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.99%

3.08%

Kitas uždarbis

2025-11-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-14B

123B

Ankstesnė atidarymo kaina

569.74

Ankstesnė uždarymo kaina

569.6

Coloplast A-S (Class B) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-03 14:47; UTC

Pagrindinės rinkos jėgos

Esperion Therapeutics Shares Rise After Blocking Generic Version of Cholesterol Drug

2025-10-03 14:25; UTC

Pagrindinės rinkos jėgos

Shopify Shares Rise as TD Cowen Raises Price Target

2025-10-03 13:20; UTC

Įsigijimai, susijungimai, perėmimai

Anglo American Initiates Arbitration Proceedings After Peabody Deal Falls Through

2025-10-03 12:40; UTC

Pagrindinės rinkos jėgos

Alto Neuroscience Shares Rise After Getting FDA Fast-Track Designation

2025-10-03 22:02; UTC

Įsigijimai, susijungimai, perėmimai

First National Financial Gets Ontario Court Approval for Sale to Birch Hill Equity and Brookfield

2025-10-03 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-03 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-10-03 19:56; UTC

Rinkos pokalbiai

Treasury Yields Have Weekly Loss as Key Statistics Go Unseen -- Market Talk

2025-10-03 19:52; UTC

Įsigijimai, susijungimai, perėmimai

This Mini-Berkshire Insurer Looks Cheap After Sale Of California Unit At High Price -- Barrons.com

2025-10-03 19:21; UTC

Rinkos pokalbiai

Crude Prices End Week Lower Ahead of OPEC Meeting -- Market Talk

2025-10-03 19:05; UTC

Rinkos pokalbiai

Natural-Gas Futures Face Mild Temperatures -- Market Talk

2025-10-03 19:04; UTC

Įsigijimai, susijungimai, perėmimai

BlackRock Group Hunts a $20 billion Deal to Get In on the AI Boom -- WSJ

2025-10-03 18:22; UTC

Rinkos pokalbiai

Bank of Canada Tentative About More Rate Cuts Due to Upside CPI Risks -- Market Talk

2025-10-03 17:15; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Decreased Last Week -- Market Talk

2025-10-03 16:26; UTC

Rinkos pokalbiai

Long-Term Treasury Yields Expected to Shrug Off Fed Cut -- Market Talk

2025-10-03 16:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-10-03 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-03 16:16; UTC

Rinkos pokalbiai

Alaska Air, American Airlines Expected to Post Disappointing 3Q Results -- Market Talk

2025-10-03 16:02; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-03 16:02; UTC

Rinkos pokalbiai

Airline Industry Bifurcation Likely to Define 3Q Earnings -- Market Talk

2025-10-03 15:17; UTC

Įsigijimai, susijungimai, perėmimai

Tech Buyouts Have Heated Up. These 8 Companies Could Be Next. -- Barrons.com

2025-10-03 14:56; UTC

Rinkos pokalbiai

European Credit Spreads Could Tighten as New Supply Stays Low -- Market Talk

2025-10-03 14:10; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-03 14:10; UTC

Rinkos pokalbiai

Sanofi Sales Could Miss Forecasts, With Adjusted Profit in Line -- Market Talk

2025-10-03 13:34; UTC

Rinkos pokalbiai

Natural Gas Futures Down Amid High Supply, Mild Demand -- Market Talk

2025-10-03 13:29; UTC

Rinkos pokalbiai

Crude Prices Rise Slightly Ahead of OPEC+ Meeting -- Market Talk

2025-10-03 13:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-10-03 13:14; UTC

Rinkos pokalbiai

Brazilian Companies Face Higher Financing Costs, Fitch Says -- Market Talk

2025-10-03 13:10; UTC

Rinkos pokalbiai

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

2025-10-03 12:52; UTC

Rinkos pokalbiai

Ferrari Results Secondary to Investor Day -- Market Talk

Akcijų palyginimas

Kainos pokytis

Coloplast A-S (Class B) Prognozė

Kainos tikslas

By TipRanks

11.86% į viršų

12 mėnesių prognozė

Vidutinis 901.38 DKK  11.86%

Aukščiausias 1,056 DKK

Žemiausias 720 DKK

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Coloplast A-S (Class B) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

4

Laikyti

2

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat